Concepedia

Author

Scott A. Van Wier

Mayo Clinic in Arizona

Also Known As

S A Van Wier, S. A. Van Wier, S.A. Van Wier, Scott A Van Wier, Scott A. Van Wier, Seth Welsh

27

Publications

2.8K

Citations

17

H-Index

24

Concepts

All Affiliations

Mayo Clinic in ArizonaMayo ClinicDana-Farber Cancer InstituteWinnMedMayo Clinic in Florida
SA

About

Scott A. Van Wier is an author at Mayo Clinic in Arizona specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

776

2

Health Sciences

3

3

225

3

Cell Biology

3

3

453

4

Immunology

3

3

340

5

Blood Transplantation

1

1

58

Scott A. Van Wier

×

16

Publications

2.6K

Citations

16

H-Index

YearCitations

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Rafaël Fonseca, Emily Blood, Montserrat Rué,

Blood

2003

658

Genetic aberrations and survival in plasma cell leukemia

Rodger E. Tiedemann, Natalia González-Paz, Robert A. Kyle,

Leukemia

2008

340

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients

Rafaël Fonseca, Emily Blood, Martin M. Oken,

Blood

2002

337

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

Rafaël Fonseca, Scott A. Van Wier, Wee Joo Chng,

Leukemia

2006

211

Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions

Roelandt F.J. Schop, W. Michael Kuehl, Scott A. Van Wier,

Blood

2002

202

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.

Rafaël Fonseca, David Harrington, Martin M. Oken,

PubMed

2002

182

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations

Wee Joo Chng, Rafael Santana-Dávila, Scott A. Van Wier,

Leukemia

2006

134

6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis

Enrique M. Ocio, Roelandt F.J. Schop, Bernardo González González,

British Journal of Haematology

2006

116

6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance

Roelandt F.J. Schop, Scott A. Van Wier, Ruifang Xu,

Cancer Genetics and Cytogenetics

2006

98

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

Angela Baker, Esteban Braggio, Susanna Jacobus,

Blood

2013

64

Page 1